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ABSTRACT 
Introduction: In order to establish the pattern of bone remodelling caused by a 
cementless, anatomic implant, we intend to evaluate the changes in bone mineral 
density observed after surgery in the Gruen zones. 
 
Material & methods: A controlled, prospective study was carried out, in which a 
group of 37 patients suffering from primary coxarthrosis were densitrometrically 
analyzed over the one year period following the implant of an ANATO® stem 
(Stryker®). The patient's healthy hip was taken as the control. Any differences in the 
remodelling pattern were compared according to age, body mass index and implant 
size. 
 
Results: Decreases in bone mineral density were observed after 3 months in all of 
the zones studied.  However, this bone mineral density loss was recovered in all 
zones by the end of the study, except in zone 7 where a decrease of 7.2% in bone 
mass  was observed. In zones 2 and 6, where more loads are transmitted, bone 
mass preservation, in accordance with Wolff's law, can be seen. No differences were 
found in the remodelling pattern in relation to age and body mass index. Neither 
were there any differences related to stem size except in zones 1 and 7. 
 
Conclusion: the ANATO® stem achieves an efficient transmission of loads between 
the stem and the proximal femur, providing enough mechanical loads for bone 
preservation. It is only in zone 7 where significant bone atrophy can be observed, 
attributable to the damage that this area suffers during the surgical process and the 
subsequent stress-shielding caused by the implant design. 
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INTRODUCTION: 
Bone remodelling after a hip arthroplasty can be observed with all models of 
cemented and cementless femoral stems. Following the implantation of a femoral 
stem, the biomechanics of the hip change and the bone reacts to the new situation in 
accordance with Wolff’s law, in a process of adaptive remodelling (1). These 
remodelling changes are attributable to both the mechanical and biological factors 
which react to the new biomechanical situation. Among these factors are those 
which are influenced by the implant itself, such as implant size, rigidity, extension of 
porous coating (2), design (3) or alloy; and factors dependent on the patient, such as 
age, weight, gender or most importantly the preoperative bone mass (BM) (4,5).  
 
Considering that a BM loss of 30-40% is required in order to observe the results in a 
plain radiograph (6), the prospective studies which use Dual Energy X-ray 
Absorptiometry (DEXA) are considered to be the ideal method to assess the 
changes in bone mass caused by different stems over the years (7,8,9) 
 
Densitometric studies with different implants have made it possible to quantify the 
influence of these factors in bone remodelling and provide information for the 
redesign of implants in use or for the design of new implants. Additionally, this 
method has proven to be reliable and precise and is considered ideal for repeated 
examinations in follow-ups due to its accuracy and low radiation (9). 
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Several studies have been published about the ABG I® prothesis (Stryker®) over the 
last two decades, with good clinical and radiological results (10,11,12), but the 
femoral stem caused notable stress-shielding, leading to 30% decreases in bone 
mass in Gruen zones 1 and 7 (13) 
The redesign of this implant (ABG-II®), matched the clinical and radiological results 
in addition to improving the bone modeling results (14). The decreases in bone mass 
dropped to 15% in the greater trochanter and calcar at 5 years, decreases which are 
noticeable 6 months after implantation (15).  
At the beginning of 2015 the development of the ABG II® implant (ANATO®) 
emerged. The modifications in the design of its components and its composition aim 
to maintain the good clinical and radiological results of its predecessors whilst 
attaining a decrease in stress-shielding to achieve greater preservation of bone 
density in the long term.  
 
The ANATO® stem is a “refinement” of an efficient, previous design. It allows for the 
choice of a neutral or anteverted neck, adapted to the anatomy of each patient.  The 
alloy has been modified, changing from TM12Z6F2 in the ABG-II® to Ti6AlV4 in the 
ANATO® stem.  In addition it has a biological coating of hydroxyapatite with greater 
porosity. Finally, the shorter stem length in the large sizes conserves more distal 
bone and improves the transmission of forces at a proximal level, which is expected 
to favour a decrease in proximal femur atrophy.  
 
The purpose of this study is to evaluate the variation in BM caused by the 
periprosthetic remodelling of this new implant (ANATO®) in a group of patients over 
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the first 12 months post operative period, taking the contralateral, healthy hip as 
control. 
 
MATERIAL AND METHODS: 
In order to know the periprosthetic remodelling caused by the ANATO® stem, a 
prospective study was designed using the healthy hip as control. We included those 
patients operated on between the months of March and September 2015. Data 
collection was carried out through the use of clinical records and anamnesis. The 
study was approved by the Ethics Committee. 
  
Densitometric evaluation: 
 
The variation in BM was taken as evaluation criterion using 30 by 30 pixel squares 
for each one of the 7 Gruen zones for both the healthy and unhealthy hip. Bone 
mass determinations were carried out with the LUNAR DPX enCORE densitometer 
(General Electrics Healthcare, Madison) using a software with metal exclusion. The 
measurements were done on both hips in the pre-op and one year after the 
operation, while measurements of the operated hip were also taken in the immediate 
postoperative period and at 3 and 6 months after the operation. In addition, the 
influence of other variables in bone remodelling, such as age and BMI, were 
evaluated at the one year stage. 
 
Changes in hip rotation during a densitometric examination are known to have an 
influence on the reliability of the measurements obtained (16). Therefore, a patient 
positioning protocol was designed in order to ensure the reliability of these 
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examinations. Quality controls were done every morning for the DXA equipment to 
verify system stability, as specified by manufacturer’s guidelines 
Study population 
The study inclusion criteria were for patients to be diagnosed for treatment with this 
type of implant due to primary coxarthrosis, not to have any radiological signs of 
osteoporosis, to have a healthy contralateral hip and to accept to participate in the 
study. 
The study group consisted of 37 patients in the ANATO® group (31 men and 6 
women), with an average  BMI of 29.2 kg/m2 (18-32; D.S. 4.50). The average age 
was 57.3 years (36-75; D.S.8.47). All patients completed the one-year follow-up. 
 
Anatomic stem 
 
The implant used was the ANATO® stem (Stryker®, USA), with a cementless cup 
(TRIDENT®) and ceramic on polyethylene wearing couple (the latter two not being 
object of this study). It is a cementless, anatomical stem, with press-fit metaphyseal 
fixation and a Ti6AlV4 alloy (Figure.1). It offers a neutral or 7º anteverted neck, 
making it possible to choose one or the other depending on the patient’s anatomy 
and intraoperative stability. At the metaphyseal level the implant has a scale design 
on the front and rear surfaces, which help to transform the axial forces into 
transversal ones thus improving the stability of the implant, in addition to a 
Hydroxyapatite PureFix® coating. 
 
From size 4 onwards, the total length of larger implants does not increase. However, 
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the metaphyseal part of the implant does, in order to adapt to the femoral 
morphology of the patients. The implant tail, which is thinner and more polished, 
retains the sole purpose of aligning the implant within the femoral canal to avoid 
varus or valgus malalignment.  
 
In summary, the fundamental differences with respect to the previous model (ABG 
II®) are: 
x Anteverted and neutral neck options. 
x Change in the alloy: Ti6AlV4 (ANATO®); TM12Z6F2 (ABG II®) 
x Shorter length and distal diameter in the large sizes of the ANATO® model 
(Figure 2) 
x Plasma Spray and biological hydroxyapatite coating with greater porosity. 
 
 
Surgical technique: 
 
All patients were operated on in the lateral decubitus position, with a posterolateral 
approach performed by the same group of 7 surgeons. Antibiotic prophylaxis was 
implemented using Cefazolin, or Teicoplanin in case of allergy, for 24 hours and 
antithrombotic treatment was carried out using low molecular weight heparins over a 
period of 30 days. 
 
The patients rested in bed for the first 24 hours, after which the drainage was 
removed from the wound. From this moment the patients began to assume the 
sitting position on the edge of the bed or in a high chair. Later, isometric exercises of 
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the lower limbs were allowed before walking with crutches or walking frames in 
partial weight bearing, depending on tolerance. 
 
The patients continued walking with partial support for 6 weeks, at which time the 
crutch of the operated hip was withdrawn and full weight bearing was allowed. At 3 
months the last crutch was removed from the health hip and free movement was 
authorized.  
      
Returning to work was allowed after 6 weeks for sedentary jobs and after 3 months 
for light physical work. Heavy physical work was not allowed. 
 
Statistical analysis 
 
The statistical study was carried out using SPSS software, version 20.0. The Chi 
square test was used for the comparison of percentages, the Student's t-test was 
used for the median with homogeneous parameters; and the Kruskall-Wallis test was 
used for the median with non-homogeneous parameters. 
 
RESULTS: 
 
The evolution of bone mass in both hips of these patients is presented in Table 1. 
The table shows the pre-operative and one-year post-op results of both hips, and the 
3 and 6 month scans of the affected hip. Postoperative values were taken as 
reference for monitoring bone mineral density in the operated hip.  
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3 months after the operation there is a generalized bone loss, visible in all of the 
areas. This is probably due to surgical rasping, which compromises the endosteal 
blood supply, and the moderate inactivity in postoperative period. 
 
However, a recovery of bone mineral density (BMD) can be seen in zones 1, 2, 3, 4, 
5 and 6 within six months of the operation, which can be attributed to the effect of 
full weight bearing.  This increase in BMD was maintained a year after the operation 
in those indicated zones. 
 
However, in zone 7 a different pattern was observed. There was a temporary 
recovery of BMD in this zone at six months, but with a subsequent loss of mineral 
density at the one year follow-up. The BMD showed a decrease of -9.9% at 3 
months, -5.3% at 6 months and -7.2% at one year, this decrease was statistically 
significant (p:0.01) 
 
When the BMD differences between age groups (Table 2) were compared at the end 
of the follow-up, the median of the sample, 57 years, was taken as the cut-off point. 
A variation of -7.8% to + 3.8% of BMD was observed in the group younger than 57, 
and there was a variation of -6.7% to + 2.5% in the group aged over 58. There were 
no statistically significant differences between the groups in any of the zones. 
 
To evaluate the BMD differences at the end of the follow-up according to body mass 
index (BMI) (Table II), the sample was divided into two groups (GROUP 1: BMI<30 
and GROUP 2: BMI>30). The cut-off point was set at 30 as it was the median of the 
sample and it divided the sample into two homogeneous groups. We found that in 
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the BMI < 30 group there were variations in BMD ranging from -11.2% to +0.7% 
while in the BMI>30 group the variations ranged between -4.4% and +5.4%. These 
differences were statistically significant in zones 1, 2 and 3 in the total comparison of 
both groups. 
 
With respect to BM evolution in the healthy hip (Table 3), which was taken as 
control, a bone mass variation of -3.2% to +0.6% was observed. These values 
ranged between -100 and + 23.4 mgr/cm2 at the end of the 12 months in the 
operated hip in contrast to the healthy hip which ranged between -30.4 and +47.4 
mgr/cm2 , with this difference being statistically significant in zone 7. 
 
Finally, when comparing the evolution of BMD between stem sizes (Table 4), some 
differences were observed. The larger, more rigid stems transmit the loads to 
the bone from the central areas of the implant to the proximal femoral isthmus, 
where denser bone is found. As a consequence, there is greater stress-
shielding and atrophy of the proximal zones, which is significant in zone 1, 
and relevant, although not statistically significant, in zone 7. There is a 
significant difference between sizes in zone 4, but it is not clinically relevant. It 
is probably due the bone loss caused by intramedullary over reaming so as to 
avoid the contact of the implant tail with the diaphyseal bone.  
 
 
DISCUSSION: 
 
The implantation of a femoral stem produces the so-called adaptive remodelling, 
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which has a multifactorial origin (17, 18, 19). 
 
In order to accurately quantify the changes in bone density which occur in the femur 
due to this process, it is essential to use DEXA in long term follow-up (20). 
 
Previous studies using densitometry to evaluate the variation in BMD of the proximal 
femur after the implantation of a cementless femoral stem show that at 3 and 6 
months after surgery, BM decreases can occur. These decreases can range from 4 
to 50 % of the initial bone mass, depending on the implant, the surgical technique 
and the methodology used for its measurement. Among the main causes of these 
losses we can mention the partial weight bearing during the first weeks after the 
operation and the immediate decrease of bone stock after femoral preparation with 
reaming and rasping, the latter being able to jeopardize up to 10 % of the initial bone 
stock (21,22).  
 
Furthermore, we must take into account that the surgical technique has an important 
influence on the changes which occur in the early period. The preparation of the 
metaphysis and the press-fit system of the implant can cause micro-fractures in the 
cancellous bone that can be reabsorbed in the following weeks, producing new 
decreases of bone mass which can be detected in the first 3 months after the 
operation.  
 
It is accepted that most remodelling stabilizes at the end of the first year post-
operation, when bone mineral density appears to reach a plateau in all the areas 
around the stem, from which point the changes reflect the biomechanical response 
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of the bone in accordance with Wolff's Law (23,24).  
 
Studies carried out on previous models of this stem (ABG-I® and ABG-II®), show a 
slight loss of bone in zones 2 to 6 12 months after implantation. However, these 
losses were already present at 3 and 6 months post-op and were more significant in 
the ABG-I® implant. In both stems, the most pronounced losses were observed in 
Gruen zones 1 and 7. The redesign of the stem (ABG II®) by widening the antero-
posterior metaphyseal diameter in addition to the ABG-II® implant’s shorter tail with 
reduced diameter, explains the decrease in bone loss in proximal zones (15), since 
this improved the transmission of loads. 
 
In our study, we also observed decreases in BMD at 3 months in all the zones 
studied, probably due to the damage suffered during surgery and the partial weight 
bearing of the operated limb. However, recovery was observed in all of the zones 
over the following months, except in zone 7, which becomes partially bypassed as it 
does not receive enough mechanical loads to favour bone recovery. In zones 2 and 
6, where more loads are transmitted, bone mass preservation is observed in 
accordance with Wolff's law.  
 
Other authors (25) have confirmed that age affects the density of trabecular and 
cortical bone. In our study, the younger patients with, in principle, better bone quality 
and more rigid femurs, were observed to have no significant remodelling differences 
when compared to the group of patients aged over 57. Hence, it is concluded that 
with this stem, age does not determine a different pattern of remodelling if the initial 
BM is conserved. 
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Some studies have determined the negative influence being overweight can have on 
the functional recovery of patients, pain management and incidence of infections 
(26). When studying the influence of BMI on remodelling, some variations in the 
pattern of remodelling between groups were observed, but only significant 
differences were found in some areas. In the BMI < 30 group, a slight loss of bone 
was observed in zones 1 to 5, bone preservation was noted in zone 6, but with the 
greatest loss being in zone 7.  In the BMI > 30 group, slight changes were observed 
in bone mass in zones 1 to 6, but the general tendency in these areas was to 
preserve bone, with slight atrophy in zone 7. The differences between these two 
groups, although statistically significant, are not clinically relevant, and can be 
attributed to the higher level of physical activity that is usually observed in patients 
with BMI <30. With these results it would seem that the body mass index does not 
bring about large differences in femoral periprosthetic remodelling after implantation 
of the ANATO® stem in the first postoperative year. 
 
When evaluating bone mass variations between the operated and healthy hip at the 
end of the post-operative year, significant differences were only found in zone 7. 
Therefore, we could conclude that in the middle and distal zones of the operated hip, 
BMD evolution is no different to the involutional changes observed in the healthy hip. 
We can also conclude that more follow-up time is needed to find any differences, 
with some studies recommending up to three years more (27). This suggests that the 
ANATO® stem, recreates a fairly physiological load pattern, which allows the 
preservation of bone mass in all areas except zone 7. 
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With regard to the variation of BMD in relation to stem size, we could see that the 
difference in the total length of the implant, according to the size of the stem, does 
not determine any other differences, to those mentioned in zones 1 and 7. This is 
because the extension of the biological layer, where the fixation and integration of 
the implant is achieved, increases proportionally to the size of the implant, seeking at 
all times to adapt to the proximal femoral morphology. The tail of the implant is for 
the sole purpose of aligning the stem, being polished and thin to avoid bone fixation 
at that level. 
 
A similar result to this was observed in a recent study, which compared bone 
remodelling between a standard length cementless stem and a shorter cementless 
stem in all seven Gruen zones at two years. At the end of the follow up, they did not 
find any statistically significant differences in periprosthetic bone loss between the 
two stems (28). 
 
It is known that differences in the angle of anteversion of the femoral neck can 
modify bone remodelling in zones 1 and 7 (29). In our case, as we used the 7º 
anteverted neck model in all the cases, we were not able to draw conclusions in this 
respect, being a point to study in future evaluations. 
 
Limitations of the study: 
 
x Firstly, the low number of patients, especially female, may be insufficient. 
Consequently a larger number would contribute more statistical power to our 
sample. 
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x Secondly, the follow-up time of one year prevents us from evaluating long-
term bone remodelling changes, although it is accepted that remodelling 
changes occur in the first postoperative year. 
 
In conclusion, the ANATO® stem allows an efficient transmission of loads from the 
stem to the proximal femur, providing enough mechanical loads for bone 
preservation. Only in zone 7 is any significant bone atrophy observed, attributable 
initially to the denervation and devascularization which this area suffers during the 
surgical technique. This causes a bone atrophy which is already visible at three 
months. The bone losses in this area were not recovered by the end of the study as 
area 7 does not receive a physiological stimulus from the stem for bone recovery.  
 
Disclosures: 
Financial support: None 
Conflict of interest: None 
 
 
 
 
 
 
 
 
 
Page 16 of 28
 17 
 
REFERENCES 
 
1. Huiskes R, Weinans H, Dalstra M. 1989. Adaptative bone remodelling and 
biomechanical design considerations for noncemented total hip arthroplasty. J 
Orthopedics. 12:1255–1267. 
 
2. McAlley J, Culpepper W, Engh CA. 1998. Total hip arthroplasty. Concerns 
with extensively porous coated femoral components. Clin Orthop.355:182-8. 
 
3. Rosenthall L, Bobyn JD, Tanzer M. 1999.Bone densitometry: influence of 
prosthetic design and hydroxyapatite coating on regional adaptative bone 
remodeling. Int Orthop. 23:325-9. 
 
4. Gibbons C, Davis A, Olearnik H, et al. 2001. Periprosthetic bone mineral 
density changes with femoral components of different design philosophy. Int 
Orthop. 25:89. 
 
5. Sychter CJ, Engh CA. 1996.The influence of clinical factor on periprosthetic 
bone remodeling. Clin Orthop. 322:285–292. 
 
6. Engh CA Jr, Mc Auley JR, Sychterz JP, Sacco CJ, M. E, Engh CA Sr. 2000. 
The Accuracy and Reproducibility of Radiographic Assessment Of Stress-
Shielding. J. Bone Joint Surg. Am. 82A: 1414–1420 
 
Page 17 of 28
 18 
7. Kroger H, Miettinen H, Arnala I, Koski  E, Rushton N, Suomalainen O. 1996. 
Evaluation of Periprosthetic Bone Using Dual Energy X-Ray Absorptiometry: 
Precision of the Method and Effect of Operation on Bone Mineral Density. J 
Bone Miner Res. 11 (10):1526–1530 
 
8. Rosenthall L, Bobyn JD, Tanzer M. 1999.  Bone Densitometry: Influence of 
Prosthetic Design and Hydroxyapatite Coating on Regional Adaptative Bone 
Remodeling. Int Orthop. 23 (6): 325–329 
 
9. Schmidt R, Nowak TE, Mueller L, Pitto R. 2004. Osteodensitometry After Total 
Hip Replacement With Uncemented Taper-Design Stem. Int Orthop.  28 (2): 
74–77 
 
10. Herrera A, Canales V, Anderson J, García-Araujo C, Murcia-Mazón A, Tonino 
AJ. 2004. Seven to 10 years followup of an anatomic hip prosthesis: an 
international study.Clin Orthop Relat Res. 423:129-37 
 
11. Tonino AJ, Rahmy AI. 2000. The hydroxyapatite-ABG hip system: 5 to 7 years 
results from an international multicenter study. The International ABG Study 
Group. J Arthroplasty. 15(3):274-82 
 
12. Bidar R, Kouyoumdjian P, Munini E, Asencio G. 2009. Long-term results of 
the ABG-1 hydroxyapatita coated total hip arthroplasty: analysis of 111 cases 
with an minimum follow-up of 10 years. Orthop Traumatol Surg Res. 
95(8):579-87.  
Page 18 of 28
 19 
 
13. Massari L, Bagni B, Biscione R, Traina GC. 1996. Periprosthetic bone density 
in uncemented hip implants with proximal hydroxiapatite coating. Bull Hops 
Joint Dis. 54 (4):206-10. 
 
14. Herrera A, Mateo J, Gil-Albarova J, Lobo-Escolar A, Ibarz E, Gabarre S, Más 
Y, Gracia L. 2015. Cementless hydroxyapatite coated hip prostheses. Biomed 
Res Int.  
 
15. Panisello JJ, Canales V, Herrero L, Herrera A, Mateo J, Caballero MJ. 2009. 
Changes in periprosthetic bone remodelling after redesigning an anatomic 
cementless stem. Int Orthop. 33(2):373–9. 
 
16. Martini F, Lebherz C, Mayer F, Leichtle U, Kremling E, Sell S. 2000. Precision 
of the measurements of periprosthetic bone mineral density around hips with 
a custom-made femoral stem. J Bone Joint Surg Am. 82: 1065-71. 
 
17. Hellman EJ, Capello WN, Feinberg JR. 1999. Omnifit cementless total hip 
arthroplasty: A 10-years average follow up. Clin Orthop. 364:164-74. 
 
18. Braun A1, Papp J, Reiter A.  2003. The periprosthetic bone remodelling 
process signs of vital bone reaction. Int Orthop. 27 Suppl 1:7-10. 
 
19. Sychterz CJ, Claus AM, Engh CA. 2002. What we have learned about long-
term cementless fixation from autopsy retrievals. Clin Orthop Relat Res. 
Page 19 of 28
 20 
405:79–91. 
 
20. Brodner W, Bitzan P, Lomoschitz F, Krepler P, Jankovsky R, Lehr S, 
Kainberger F, Gottsauner-Wolf F. 2004. Changes in bone mineral density in 
the proximal femur after cementless total hip arthroplasty. A five-year 
longitudinal study. J Bone Joint Surg Br. 86: 20-6. 
 
21. Ohta H, Kobayashi S, Saito N, Nawata M, Horiuchi H, Takaoka K. 2003. 
Sequential changes in periprosthetic bone mineral density following total hip 
arthroplasty: a 3-year follow-up. J Bone Miner Metab. 21:229-33. 
 
22. Kobayashi O, Saito N, Nawata M. 2003. Sequential changes in periprosthetic 
bone mineral density following total hip arthroplasty: a 3-year follow-up. J 
bone Miner Metab. 21:9. 
 
23. Kärrholm J, Anderberg C, Snorrason F, Thanner J, Langeland N, Malchau H, 
Herberts P. 2002. Evaluation of a femoral stem with reduced stiffness. A 
randomized study with use of radiostereometry and bone densitometry. J 
Bone Joint Surg Am. 84:1651–1658. 
 
24. Theis JC, Beadel G. 2003. Changes in proximal femoral bone mineral density 
around a hydroxyapatite-coated hip joint arthroplasty. J Orthop Surg (Hong 
Kong) 11:48–52. 
 
 
Page 20 of 28
 21 
25. Ahlborg H, Johnell O, Karlsson M. 2004. An age-related medullary expansion 
can have implications for the long-term fixation of hip prostheses. Acta Orthop 
Scand. 75:154. 
 
26. Atwood SA; Van Citters DW; Patten EW; Furmanski J; Ries MD; Pruitt LA. 
2011. Tradeoffs amongst fatigue, wear, and oxidation resistance of cross-
linked ultra-high molecular weight polyethylene. J Mech Behav Biomed Mater 
. 4(7):1033-45. 
 
27. Rahmy AI, Gosens T, Blake GM, Tonino A, Fogelman I. 2004. Periprosthetic 
bone remodelling of two types of uncemented femoral implant with proximal 
hydroxyapatite coating: a 3-year follow-up study addressing the influence of 
prosthesis design and preoperative bone density on periprosthetic bone loss. 
Osteoporos Int. 15(4):281-9. 
 
28. Schilcher J, Ivarsson I, Perlbach R, Palm L. 2016.No Difference in 
periprosthetic bone loss and fixation between a standard-length stem and a 
shorter version in cementless total hip arthroplasty. A randomized controlled 
trial. J Arthroplasty.  
 
29. Hayashi S, Hashimoto S, Kanzaki N, Kuroda R, Kurosaka. 2016. Stem 
anteversion affects periprosthetic bone mineral density after total hip 
arthroplasty.  MHip Int. 26(3):260-4. 
Page 21 of 28
 22 
Figure 1: Image of the two implants used. The ANATO stem (left) and the ABG-II 
stem (right) 
 
Figure 2: Image of two cases, not included in this study, to show the difference in 
length between the ABG II stem and the ANATO stem according to stem size. In the 
image on the left, a size 4 ABG II stem in the right hip and a size 4 ANATO stem in 
the left hip, showing that both implants are the same length. In the image on the 
right, a size 6 ABG II stem in the right hip and a size 6 ANATO stem in the left hip, 
showing the difference in length between one and the other despite being the same 
size. 
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TABLE I. Evolution of bone mass in both hips over one year 
 
Gruen 
Zones 
 
Pre-op 
 
Post-op 
Reference 
 
3 months 
 
6 months 
 
1 year 
 
Healthy-Preop 
Control 
 
 
Healthy  
1 year 
Area 1 
Variation 
P 
917 
 
 
918 884 
-3,7% 
0,879 
922 
0,40% 
0,488 
901 
-1,80% 
0,211 
964 933 
-3,20% 
0,023 
Area 2 
Variation 
P 
1599 
 
 
1823 
 
 
1778 
-2,4% 
0,54 
1844 
1,10% 
0,474 
1846 
1,20% 
0,237 
1684 1671 
-0,70% 
0,706 
Area 3 
Variation 
P 
1970 
 
 
2132 
 
 
2042 
-4,2% 
0,628 
2148 
0,70% 
0,423 
2155 
1,10% 
0,418 
2044 2022 
-1,70% 
0,184 
Area 4 
Variation 
P 
2108 
 
 
2067 
 
 
2012 
-3% 
0,47 
2029 
-1,80% 
0,671 
2043 
-1,10% 
0,332 
2127 2076 
-2,30% 
0,001 
Area 5 
Variation 
P 
2039 
 
 
2118 
 
 
2010 
-5% 
0,046 
2076 
-1,90% 
0,177 
2090 
-1,30% 
0,448 
2085 2054 
-1,40% 
0,02 
Area 6 
Variation 
P 
1647 
 
 
1695 
 
 
1622 
-4,3% 
0,063 
1694 
-0,10% 
0,977 
1730 
2,0% 
0,337 
1715 1672 
-2,50% 
0,06 
Area 7 
Max-Min 
p 
1224 
 
 
1375 
 
 
1250 
-9,9% 
0,001 
1301 
-5,30% 
0,041 
1275 
-7,2% 
0,01 
1231 1239 
0,60% 
0,669 
Changes in bone density, in both the operated and healthy hip for the ANATO stem, during the follow-up. Bone density is 
expressed in mg of hydroxyapatite per cm2. The percentage of variation is related to the post-operative scan, considered as 
the baseline values. 
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TABLE 2: Differences at the end of the follow-up according to age and body 
mass index 
  BMI up to 30 
(n=19) 
BMI over 30  
(n= 18) 
 Up to 57 years 
old (n = 18) 
Over 57 years 
old (n= 19) 
 Gruen 
Zones 
BMD 
postop 
BMD  
12 m 
BMD 
postop 
BMD 
12 m 
p-
value 
BMD 
postop 
BMD 
12 m 
BMD 
postop 
BMD  
12 m 
p-
value 
Área 1 
% 
variation 
P value 
922 
 
881 
-4.4% 
0.296 
911 
 
941 
+3.2% 
0.312 
0.034 909 
 
906 
-0.3% 
0.910 
926 
 
895 
-3.3% 
0.474 
0.357 
Área 2 
% 
variation 
P value 
1836 
 
1800 
-1.9% 
0.432 
1802 
 
1901 
+5.4% 
0.029 
0.028 1849 
 
1888 
+2.1% 
0.300 
1798 
 
1807 
+0.5% 
0.877 
0.852 
Área 3 
% 
variation 
P value 
2114 
 
2089 
-1.2% 
0.499 
2118 
 
2233 
+5.4% 
0.003 
0.039 2138 
 
2220 
+3.8% 
0.114 
2126 
 
2094 
-1.5% 
0.497 
0.788 
Área 4 
% 
variation 
P value 
2052 
 
1995 
-2.7% 
0.102 
2078 
 
2096 
+0.8% 
0.624 
0.174 2068 
 
2067 
-0.1% 
0.997 
2067 
 
2021 
-2.2% 
0.265 
0.904 
Área 5 
% 
variation 
P value 
2085 
 
2024 
-2.9% 
0.159 
2149 
 
2160 
+0.5% 
0.874 
0.434 2112 
 
2098 
-0.6% 
0.814 
2125 
 
2083 
-1.9% 
0.378 
0.483 
Área 6 
% 
variation 
P value 
1673 
 
1686 
+0.7% 
0.833 
1686 
 
1752 
+3.9% 
0.188 
0.274 1653 
 
1679 
+1.5% 
0.554 
1734 
 
1778 
+2.5% 
0.463 
0.387 
Área 7 
% 
variation 
P value 
1362 
 
1209 
-
11.2% 
0.002 
1388 
 
1327 
-4.4% 
0.358 
0.185 1381 
 
1273 
-7.8% 
0.050 
1370 
 
1278 
-6.7% 
0.102 
0.612 
Comparision of bone remodelling determined by the stem according to BMI and age. Bone density is expressed 
in mg of hydroxyapatite per cm2. The percentage of variation is related to the post-operative scan, considered as 
the basel 
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TABLE III. Bone mineral evolution in the healthy hip 
Difference BMD 
At 1 year n=37 
 
CASES 
 
Control 
(healthy) 
 
p 
F1 -17,3 
 
28,6 
 
0,696 
F2 
 
23,4 
 
4,5 
 
0,593 
F3 
 
23,2 
 
10,2 
 
0,307 
F4 -23,7 
 
47,4 
 
0,339 
F5 
 
-28 
 
-30,4 
 
0,951 
F6 
 
35,3 
 
42,4 
 
0,105 
F7 
 
-100,1 
 
-18,1 
 
0,010 
Bone density changes in the contralateral, healthy hip throughout the follow-up. Bone density is expressed in mg of 
hydroxyapatite 
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TABLE IV. Comparation the evolution of bone mineral density between stem 
sizes 
Gruen 
Zones 
(size <= 4) 
15 days 
 
  3 m 
 
  6m 
 
12 m 
(size >5) 
15 days 
 
3 m 
 
  6 m 
 
 12 m 
 
     p 
 
Area 1 
900 886 
-1.5% 
931 
+3.4% 
920 
+2.2% 
940 852 
-9.3% 
892 
-5.1% 
869 
-7.5% 
0,034 
 
Area 2 
1799 1771 
-1.5% 
1839 
+2.2% 
1821 
+1.2% 
1858 1780 
-4.1% 
1848 
-0.5% 
1899 
+2.2% 
0,951 
 
Area 3 
2082 2015 
-3.2% 
2124 
+2.0% 
2133 
+2.4% 
2211 2073 
-6.2% 
2177 
-1.5% 
2195 
-0.7% 
0,265 
 
Area 4 
2008 1971 
-1.8% 
1995 
-0.6% 
2036 
+1.3% 
2143 2052 
-4.2% 
2065 
-3.6% 
2042 
-4.7% 
0,012 
 
Area 5 
2053 1942 
-5.4% 
2033 
-0.9% 
2048 
-0.2% 
2189 2081 
-4.9% 
2119 
-3.1% 
2133 
-2.5% 
0,543 
 
Area 6 
1666 1592 
-4.4% 
1644 
-1.3% 
1687 
+1.2% 
1710 1655 
-3.2% 
1748 
+2.2% 
1800 
+5.2% 
0,442 
 
Area 7 
1352 1251 
-7.4% 
1329 
-1.7% 
1309 
-3.1% 
1386 1238 
-10.6% 
1234 
-10.9% 
1206 
-12.9% 
0,121 
Comparison of bone remodelling between stem sizes. Bone density is expressed in mg of hydroxyapatite per cm2. The 
percentage of variation is related to the post-operative scan, considered as the baseline values.  
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